PATENCY OF THE DUCTUS ARTERIOSUS ACETAMINOPHEN EXTREME PREMATURITY

Clinical trials for PATENCY OF THE DUCTUS ARTERIOSUS ACETAMINOPHEN EXTREME PREMATURITY explained in plain language.

Never miss a new study

Get alerted when new PATENCY OF THE DUCTUS ARTERIOSUS ACETAMINOPHEN EXTREME PREMATURITY trials appear

Sign up with your email to follow new studies for PATENCY OF THE DUCTUS ARTERIOSUS ACETAMINOPHEN EXTREME PREMATURITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a common painkiller boost brain development in preterm babies?

Knowledge-focused Recruiting now

This study follows up on 500 extremely preterm infants who received paracetamol or a placebo in a previous trial to see if early treatment helps close a heart vessel and improves thinking skills at age 2. Parents will answer online questionnaires about their child's development. …

Matched conditions: PATENCY OF THE DUCTUS ARTERIOSUS ACETAMINOPHEN EXTREME PREMATURITY

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused

Last updated Apr 29, 2026 15:02 UTC

PATENCY OF THE DUCTUS ARTERIOSUS ACETAMINOPHEN EXTREME PREMATURITY

Get alerted when new PATENCY OF THE DUCTUS ARTERIOSUS ACETAMINOPHEN EXTREME PREMATURITY trials appear

Could a common painkiller boost brain development in preterm babies?